The preferred method of ctDNA detection is through Next-Generation Sequencing (NGS), which has become a mandatory component in lung cancer management, being a standard in the detection of ALK, EGFR, and BRAF mutations amongst many others, which helps in making treatment decisions [7]. The gene discussed is ALK; the disease is lung carcinoma.